Supply Of Exclusive Medicines With Active Principles Fampridina, Natalizumab, Nusinersen And Peginterferon Beta-1A Of The Pharmaceutical Laboratory Biogen Spain S.L. Through Negotiated Procedure For Exclusivity Without Advertising.

Name: Supply Of Exclusive Medicines With Active Principles Fampridina, Natalizumab, Nusinersen And Peginterferon Beta-1A Of The Pharmaceutical Laboratory Biogen Spain S.L. Through Negotiated Procedure For Exclusivity Without Advertising.
Start: 2025-07-18
End: -0001-11-30
Location: Servicio Murciano de Salud - Junta de Compras

Servicio Murciano de Salud - Junta de Compras Spain has Released a tender for Supply Of Exclusive Medicines With Active Principles Fampridina, Natalizumab, Nusinersen And Peginterferon Beta-1A Of The Pharmaceutical Laboratory Biogen Spain S.L. Through Negotiated Procedure For Exclusivity Without Advertising. in Pharmaceuticals. The tender was released on Jul 18, 2025.

Country - Spain

Summary - Supply Of Exclusive Medicines With Active Principles Fampridina, Natalizumab, Nusinersen And Peginterferon Beta-1A Of The Pharmaceutical Laboratory Biogen Spain S.L. Through Negotiated Procedure For Exclusivity Without Advertising.

Deadline - login to view

GT reference number - 113645158

Product classification - Other nervous system medicinal products

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 113645158

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: SUPPLY OF EXCLUSIVE MEDICINES WITH ACTIVE PRINCIPLES FAMPRIDINA, NATALIZUMAB, NUSINERSEN AND PEGINTERFERON BETA-1A OF THE PHARMACEUTICAL LABORATORY BIOGEN SPAIN S.L. through negotiated procedure for exclusivity without advertising.local title:: suministro de medicamentos exclusivos con principios activos fampridina, natalizumab, nusinersen y peginterferon beta-1a del laboratorio farmacéutico biogen spain s.l. mediante procedimiento negociado por exclusividad sin publicidad.Contract Duration: : 24 MONTHContract Type: : Supplylocal description: : suministro de medicamentos exclusivos con principios activos fampridina, natalizumab, nusinersen y peginterferon beta-1a del laboratori

Gt Ref Id - 113645158

Deadline - Nov 30, -0001